Hantavirus infection in North America: A clinical review

American Journal of Emergency Medicine

Volumn 31, Issue 6, 2013, Pages 978-982

  Hartline, James ^a   Mierek, Chris ^a   Knutson, Tristan ^a   Kang, Christopher ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; DOBUTAMINE; ELECTROLYTE; HYPERTENSIVE FACTOR; INACTIVATED VIRUS VACCINE; NORADRENALIN; RIBAVIRIN; VACCINE; VANDETANIB; VASCULOTROPIN RECEPTOR;

ARTIFICIAL VENTILATION; CARDIOPULMONARY FUNCTION; CHILL; CLINICAL FEATURE; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FEVER; HANTAVIRUS; HANTAVIRUS INFECTION; HEMOCONCENTRATION; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LEUKOCYTOSIS; LUNG EDEMA; MYALGIA; NAUSEA; NONHUMAN; NORTH AMERICA; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; RODENT; RURAL AREA; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TRAVEL; WILDERNESS;

HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS; NORTH AMERICA; PROGNOSIS; TRAVEL; UNITED STATES;

EID: 84879080133     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2013.02.001     Document Type: Review

References (44)

1. Hantavirus: "Outbreak of Hantavirus Infection in Yosemite National Park". Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/outbreaks/yosemite-national-park-2012.html Updated 1 November 2012. Accessed 31 January 2013
2. P. Jaret "Long Wait and Worry for a Visitor to Yosemite." The New York Times http://www.nytimes.com/2012/09/18/health/waiting-and-worrying- after-yosemite-hantavirus-outbreak.html Updated 17 September 2012. Accessed 17 September 2012
3. K. Mather "Hantavirus in Yosemite: New batch of park visitors notified." The Los Angeles Times http://latimesblogs.latimes.com/lanow/ 2012/09/hantavirus.html Updated 14 September 2012. Accessed 17 September 2012.
4. "Tests confirm NY professor contracted Hantavirus." The Wall Street Journal http://online.wsj.com/article/AP50025f0449824e5f848157b38937d672. html Updated 22 October 2012. Accessed 30 October 2012
5. A. Plyusnin, and S.P. Morzunov Virus evolution and genetic diversity of hantaviruses and their rodent hosts Curr Top Microbiol Immunol 256 2001 47 75
6. C.J. Peters, and A.S. Khan Hantavirus pulmonary syndrome: the new American hemorrhagic fever Clin Infect Dis 34 2002 1224 1231
7. A. Khan, and A.S. Khan Hantaviruses: a tale of two hemispheres Panminerva Med 45 1 2003 43 51
8. C. Jonsson Global perspective on hantavirus ecology, epidemiology, and disease Clin Microbiol Rev 23 2 2010 April 412 441
9. D.A. Enria, A.M. Briggiler, N. Pini, and S. Levis Clinical manifestations of New World hantaviruses Curr Top Microbiol Immunol 256 2001 117 134
10. H.W. Lee, P.-W. Lee, and K.M. Johnson Isolation of the etiologic agent of Korean hemorrhagic fever J Infect Dis 137 1978 298 308
11. C.J. Peters, G.L. Simpson, and H. Levy Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome Annu Rev Med 50 1999 531 545
12. C.B. Jonsson, J. Hooper, and G. Mertz Treatment of Hantavirus pulmonary syndrome. Antiviral Res 78 2008 162 169 http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2810485/
13. C. Schmaljohn, and B. Hjelle Hantaviruses: a global disease problem Emerg Infect Dis 3 2 1997 95 104
14. Y.Z. Zhang, Y. Zou, Z.F. Fu, and A. Plyusnin Hantavirus infections in humans and animals, China Emerg Infect Dis 16 8 2010 1195 1203
15. CDC Emergency Preparedness and Response: Bioterrorism Agents/Diseases http://emergency.cdc.gov/agent/agentlist-category.asp Accessed 25 January 2013
16. M.S. Bronze, M.M. Huycke, L.J. Machado, G.W. Voskuhl, and R.A. Greenfield Viral agents as biological weapons and agents of bioterrorism Am J Med Sci 323 2002 316 325
17. "NIAID Category A, B, and C Priority Pathogens." National Institute of Allergy and Infectious Disease Last Updated February 27, 2012 http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/cata.aspx Accessed 27 January 2013
18. "Reported Cases of HPS." Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/surveillance/index.html Updated 29 August 2012. Accessed 31 January 2013
19. "US HCPS cases by state of exposure." Centers for Disease Control and Prevention http://www.cdc.gov/hantavirus/surveillance/state-of- exposure.html Updated 14 December 2012. Accessed 25 January 2013
20. S.R. Zaki, A.S. Khan, R.A. Goodman, L.R. Armstrong, P.W. Greer, and L.M. Coffield Retrospective diagnosis of Hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases Arch Pathol Lab Med 120 2 1996 Feb 134 139
21. "Hantavirus infection - southwestern United States: Interim recommendations for risk reduction." Centers for Disease Control and Prevention MMWR Morb Mortal Wkly Rep 42 RR-11 1993 i-13
22. L.R. Armstrong, and S.R. Zaki Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures J Infect Dis 172 1995 1166
23. B. Chang, M. Crowley, M. Campen, and F. Koster Hantavirus cardiopulmonary syndrome Semin Respir Crit Care Med 28 2007 193 200
24. G.J. Mertz, B. Hjelle, M. Crowley, G. Iwamoto, V. Tomicic, and P.A. Vial Diagnosis and treatment of new world hantavirus infections Curr Opin Infect Dis 19 2006 437 442
25. "Hantavirus Technical/Clinical Information." Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/technical/ index.html Updated 29 August 2012. Accessed 17 October 2012
26. I. Gavrilovskaya, E. Gorbunova, F. Koster, and E. Mackow Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome Adv Virol. 2012 2012 674360
27. G.W. Hallin, and S.Q. Simpson Cardiopulmonary manifestations of hantavirus pulmonary syndrome Crit Care Med 24 2 1996 Feb 252 258
28. F.P. Saggioro, and M.A. Rossi Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome J Infect Dis 195 10 2007 1541 1549
29. A. Abel Borges, and L.T. Figueiredo Mechanisms of shock in hantavirus pulmonary syndrome Curr Opin Infect Dis 21 3 2008 293 297
30. "Hantavirus Technical/Clinical Information: Clinical Manifestation." Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/technical/hps/clinical-manifestation.html Updated 29 August 2012. Accessed 17 October 2012
31. L.H. Ketai, M.R. Williamson, R.J. Telepak, H. Levy, F.T. Koster, and K.B. Nolte Hantavirus pulmonary syndrome: radiographic findings in 16 patients Radiology 191 1994 665 668
32. F. Koster, K. Foucar, and B. Hjelle Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review Am J Clin Pathol 116 2001 665 672
33. "Diagnostics." Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/technical/hps/diagnostics.html Updated 29 August 2012. Accessed 17 October 2012
34. "Hantavirus Case Definition." Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/health-care-workers/hps-case- definition.html Updated 29 August 2012. Accessed 17 October 2012
35. "Alert and Guidance for Physicians with Patients Presenting with Concerns or Symptoms of Hantavirus Pulmonary Syndrome after Visit to Yosemite National Park." California Department of Public Health http://www.cdph.ca. gov/HealthInfo/discond/Documents/HANTAGuidanceForClinicians9-12.pdf 5 September 2012
36. "Hantavirus Technical/Clinical Information: Treatment." Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/hantavirus/ technical/hps/treatment.html Updated 29 August 2012. Accessed31 January 2013
37. J.A. Wernly, C.A. Dietl, and C.E. Tabe Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment Eur J Cardiothorac Surg 40 2011 1334 1340
38. J.D. Frizzell, and M.A. Boivin Correspondence: breathtaking journey N Engl J Med 367 2012 1473 1474
39. J.W. Huggins, and C.M. Hsiang Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome J Infect Dis 164 1991 1119 1127
40. J.M. Rusnak, and W.R. Byrne Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea Antiviral Res 81 1 2009 68 76
41. E. Dolgin Hantavirus treatments advance amidst outbreak in US park Nat Med 18 10 2012 1448
42. H.W. Cho, C.R. Howard, and H.W. Lee Review of an inactivated vaccine against hantaviruses Intervirology 45 4-6 2002 328 333
43. C.S. Schmaljohn Vaccines for hantaviruses: progress and issues Expert Rev Vaccines 11 5 2012 511 513
44. C. Schmaljohn Vaccines for hantaviruses Vaccine 27 Suppl 4 2009 Nov 5 D61 D64